Affiliation:
1. Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda-151401, India
2. Department of Pharmacy,
Noakhali Science and Technology University, Sonapur, Noakhali-3814, Bangladesh
Abstract
Aims:
The aim of this study is to determine the potential adverse effects associated
with the prolonged administration of Zingiber roseum rhizome extract.
Background:
This study aimed to evaluate the sub-chronic toxicity of Z. roseum, commonly
known as rosy ginger, using a mouse model. Z. roseum has been traditionally used for its medicinal
properties; however, there is limited information regarding its potential toxic effects.
Objective:
The objective of this study is to assess the safety profile of ZRR extract at various doses
and conduct a detailed analysis of hematological, biochemical, and histological parameters regarding
sub-chronic toxicity.
Methods:
Mice were orally administered ZRR methanolic extract at doses of 300, 600, and 1200
mg/kg for 14 days as per the guidelines of ‘The Brazilian Agency of National Health Surveillance.’
Subchronic toxicity was conducted by monitoring multiple indicators, including changes in
body weight, food and water consumption, blood profile (HB, RBC, WBC, and PLT), and biochemical
markers (ALT, AST, ALP, TP, ALB, TC, TG, HDL, LDL, Creatinine, and Urea) and histopathological
examination of the liver.
Results:
Throughout the study, the mice showed normal behavior and appeared healthy. The administration
of Z. roseum at all tested doses did not significantly affect body weight, food, and water
intake, blood, biochemical markers, or liver. Z. roseum at these doses was safe, with no fatalities
or harm.
Conclusion:
Lastly, the sub-chronic administration of Z. roseum at doses of 300, 600, and 1200
mg/kg in a mice model did not elicit any toxic effects, indicating its potential safety as a therapeutic
agent.
Publisher
Bentham Science Publishers Ltd.